|
April
2010
 Quanta
Biodesign and Chemic Laboratories Inc. formed a joint cooperation agreement
that enables the two pharmaceutical development and manufacturing firms
to cooperate on a variety of client engagements, primarily in the areas
of dPEG® cGMP manufacturing. Under this agreement, the companies
can now leverage their collective expertise in synthetic chemistry and
manufacturing offering our clients a stream lined process to move from
R&D materials needs (Preclinical through phase I) to cGMP material needs
(Phase II and beyond).
|
